Cargando…
New Approaches to Targeted Therapy in Melanoma
SIMPLE SUMMARY: Immune checkpoint inhibitors and BRAF/MEK inhibitors are the cornerstone of treatment for melanoma; however, primary and acquired resistance to these therapies highlight an ongoing, unmet need to develop novel treatment modalities. The emergence of monoclonal antibodies and small mol...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296143/ https://www.ncbi.nlm.nih.gov/pubmed/37370834 http://dx.doi.org/10.3390/cancers15123224 |